Mannatech (NASDAQ:MTEX) Now Covered by Analysts at StockNews.com

StockNews.com assumed coverage on shares of Mannatech (NASDAQ:MTEX) in a report released on Thursday morning. The firm issued a buy rating on the stock.

Mannatech Trading Up 0.2 %

Shares of MTEX opened at $8.05 on Thursday. The stock has a fifty day moving average price of $7.54 and a two-hundred day moving average price of $7.59. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.62 and a current ratio of 1.17. Mannatech has a 52-week low of $6.75 and a 52-week high of $10.51. The company has a market cap of $15.17 million, a price-to-earnings ratio of -9.04 and a beta of 1.17.

Mannatech (NASDAQ:MTEX) last issued its quarterly earnings data on Tuesday, August 13th. The company reported ($0.33) earnings per share (EPS) for the quarter. Mannatech had a negative net margin of 0.97% and a negative return on equity of 11.87%. The business had revenue of $27.74 million during the quarter.

Insider Activity

In other news, Director Larry A. Jobe sold 16,288 shares of Mannatech stock in a transaction on Monday, September 9th. The stock was sold at an average price of $7.75, for a total value of $126,232.00. Following the completion of the sale, the director now directly owns 54,721 shares of the company’s stock, valued at approximately $424,087.75. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 41.50% of the company’s stock.

Mannatech Company Profile

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.